Urography in MyelomatosisBr Med J 1969; 1 doi: https://doi.org/10.1136/bmj.1.5642.486 (Published 22 February 1969) Cite this as: Br Med J 1969;1:486
- M. T. Cwynarski,
- H. M. Saxton
To investigate whether urographic contrast media might precipitate Bence Jones protein in the renal tubules and lead to renal failure in patients with myelomatosis, the reaction between the media and myeloma urine was studied in vitro. Appreciable precipitation was found only in urine at or below pH 4·5, and its occurrence did not correlate with the type or concentration of protein present. It is concluded that the risk of urography in myelomatosis is very small.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial